Skip to content

Clinical Evaluation of the CM-1500 During Hemodialysis

Clinical Evaluation of the CM-1500 During Hemodialysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05125848
Enrollment
15
Registered
2021-11-18
Start date
2021-11-29
Completion date
2022-03-04
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis, Fluid Loss

Brief summary

The study is a prospective, single-arm, non-randomized, non-blinded, non-controlled, non-significant risk, single center study enrolling up to 20 subjects consented to undergo a hemodialysis session as a part of their standard prescribed treatment plan. Subjects will consent to undergo non-invasive monitoring with the CM-1500 during three (3) separate sequential hemodialysis sessions.

Interventions

DEVICECM-1500

The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors five (5) parameters of a patient's body. A combination of these parameters is represented by a single number known as the Relative Index value. This value is indicative of relative changes in fluid volume.

Sponsors

Zynex Monitoring Solutions
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability to provide written informed consent * Ability and willingness to comply with the study procedures and duration requirements, including connection of the device to the left wrist/hand and maintaining relatively motionless during the session * 18 years of age or older * Planned to undergo a minimum of three (3) hemodialysis sessions within the two (2) weeks following enrollment.

Exclusion criteria

* Females who are pregnant or breastfeeding * Undergone an amputation of the left upper extremity * Subjects with left arm hemodialysis access only * Diagnosed with dextrocardia * Subjects who have a pacemaker * Subjects who have any other underlying condition that would inhibit completion of participation in the study, per Investigator opinion

Design outcomes

Primary

MeasureTime frameDescription
Average Relative Index Value Following a Hemodialysis ProcedureDuration of post-hemodialysis recovery period (10-minutes)The primary objective is to characterize the average CM-1500 Relative Index (RI) following a hemodialysis procedure. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline. The average RI after dialysis procedure was calculated by averaging all measured RI values for all subject sessions (3 sessions per subject, totaling 45 sessions) during the 10-min post-hemodialysis recovery period.

Secondary

MeasureTime frameDescription
Mean Intrasubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis SessionsDuration of standard dialysis procedure (Range: 131 to 241 minutes)The secondary objective is to characterize intrasubject variability in RI changes across 3 hemodialysis sessions. Cohort intrasubject variability was calculated by averaging individual subject standard deviations across enrollments. Variability for each subject is calculated by finding the RI mean and standard deviation for all RI values (1 per sec) during all 3 monitoring sessions. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set min. or max. where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.
Mean Intersubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis SessionsDuration of standard dialysis procedure (Range: 131 to 241 minutes)The secondary objective is to characterize intersubject variability in RI changes across 3 hemodialysis sessions. Intersubject variability was calculated by finding the mean and standard deviation of the variability (standard deviation) from the mean RI values (1 value per sec) for each hemodialysis session monitoring period (3 sessions x 15 subjects = 45 individual monitoring sessions). The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set min. or max., where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Hemodialysis Single Group Assignment
All enrolled subjects will be connected to the CM-1500 for monitoring during their hemodialysis session CM-1500: The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors five (5) parameters of a patient's body. A combination of these parameters is represented by a single number known as the Relative Index value. This value is indicative of relative changes in fluid volume.
15
Total15

Baseline characteristics

CharacteristicHemodialysis Single Group Assignment
Age, Continuous52.2 years
STANDARD_DEVIATION 16.1
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
15 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 15
other
Total, other adverse events
1 / 15
serious
Total, serious adverse events
0 / 15

Outcome results

Primary

Average Relative Index Value Following a Hemodialysis Procedure

The primary objective is to characterize the average CM-1500 Relative Index (RI) following a hemodialysis procedure. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set minimum or maximum, where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline. The average RI after dialysis procedure was calculated by averaging all measured RI values for all subject sessions (3 sessions per subject, totaling 45 sessions) during the 10-min post-hemodialysis recovery period.

Time frame: Duration of post-hemodialysis recovery period (10-minutes)

ArmMeasureValue (MEAN)Dispersion
Hemodialysis Single Group AssignmentAverage Relative Index Value Following a Hemodialysis Procedure93.05 Relative Index (RI)Standard Deviation 0.43
Secondary

Mean Intersubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis Sessions

The secondary objective is to characterize intersubject variability in RI changes across 3 hemodialysis sessions. Intersubject variability was calculated by finding the mean and standard deviation of the variability (standard deviation) from the mean RI values (1 value per sec) for each hemodialysis session monitoring period (3 sessions x 15 subjects = 45 individual monitoring sessions). The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set min. or max., where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Time frame: Duration of standard dialysis procedure (Range: 131 to 241 minutes)

ArmMeasureValue (MEAN)Dispersion
Hemodialysis Single Group AssignmentMean Intersubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis Sessions2.91 Relative Index (RI)Standard Deviation 3.27
Secondary

Mean Intrasubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis Sessions

The secondary objective is to characterize intrasubject variability in RI changes across 3 hemodialysis sessions. Cohort intrasubject variability was calculated by averaging individual subject standard deviations across enrollments. Variability for each subject is calculated by finding the RI mean and standard deviation for all RI values (1 per sec) during all 3 monitoring sessions. The RI is an investigational value which utilizes proprietary algorithms to combine the changes of multiple measured parameters (utilizing a weighted summation of percent change values) which are indicative of relative changes in fluid volume in adult patients into a single value. The RI is a unitless value with no set min. or max. where 100 is a patient's baseline. Based on the nature of the RI itself, a direct interpretation of a positive or negative outcome cannot be derived from the absolute value, instead it could be used to monitor trending of a patient's parameters relative to their baseline.

Time frame: Duration of standard dialysis procedure (Range: 131 to 241 minutes)

Population: Each subject was monitored for 3 separate hemodialysis sessions. Intrasubject variability was determined by comparing the 3 sessions for each subject against each other.

ArmMeasureValue (MEAN)Dispersion
Hemodialysis Single Group AssignmentMean Intrasubject Variability (Standard Deviation) in Relative Index (RI) During Hemodialysis Sessions2.27 Relative Index (RI)Standard Deviation 2.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026